|
|
Volumn 10, Issue 1 Suppl 1, 2008, Pages 4-12
|
|
Risk-based classification of hypertension and the role of combination therapy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN RECEPTOR;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
CARDIOVASCULAR DISEASE;
CLASSIFICATION;
DRUG ANTAGONISM;
DRUG COMBINATION;
HUMAN;
HYPERTENSION;
PRACTICE GUIDELINE;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
CALCIUM CHANNEL BLOCKERS;
CARDIOVASCULAR DISEASES;
DIURETICS;
DRUG THERAPY, COMBINATION;
GUIDELINES AS TOPIC;
HUMANS;
HYPERTENSION;
RECEPTORS, ANGIOTENSIN;
RISK ASSESSMENT;
RISK FACTORS;
MLCS;
MLOWN;
|
|
EID: 40949165420
PISSN: 15246175
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1524-6175.2007.08134.x Document Type: Review |
|
Times cited : (16)
|
|
References (70)
|
